Diabetes comprises a collection of metabolic disorders in which chronic hyperglycaemia arises as a result of insulin deficiency, insulin resistance, or a combination of the two.
Featured Learning Zones
There are three main types of diabetes. The most common, Type 2 diabetes, is often secondary to weight gain and involves impaired insulin secretion and the development of insulin resistance.
Type 1 diabetes is characterised by absolute insulin deficiency resulting from autoimmune destruction of the β-cells of the pancreas.
Gestational diabetes occurs when the pancreas fails to produce sufficient insulin to compensate for the state of increased insulin resistance that occurs during pregnancy.
Symptoms of diabetes include polyuria, thirst, infections and blurred vision, with suspected cases confirmed using blood tests.
Long-term diabetes is associated with various microvascular complications including retinopathy and nephropathy, as well as macrovascular disease, so effective treatment to normalise blood glucose levels is vital. While patients with type 1 diabetes require treatment with insulin, early type 2 diabetes can often be managed through lifestyle modifications, although glucose lowering agents may be required, particularly as the disease progresses.
Related news and insights
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, announced it has received CE mark approval under the European Medical Device Regulation for the added compatibility of the Abbott FreeStyle Libre 2 Plus sensor with Insulet’s Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes
Abbott and Tandem Diabetes Care, Inc. a leading insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump with Control-IQ technology is the first automated insulin delivery (AID) system to integrate with the newly available FreeStyle Libre 2 Plus sensor, Abbott’s latest continuous glucose monitoring (CGM) technology.